Literature DB >> 31476373

Treatment of Diuretic Resistance with a Novel Percutaneous Blood Flow Regulator: Concept and Initial Experience.

Riet Dierckx1, Marc Vanderheyden2, Ward Heggermont2, Marc Goethals2, Sofie Verstreken2, Jozef Bartunek2.   

Abstract

Diuretic resistance in acute heart failure is a common clinical problem, and it is associated with adverse outcomes. Effective therapies are still lacking. The Doraya catheter, a temporary intravenous flow regulator placed in the inferior vena cava below the level of the renal veins, is a novel device designed to target renal and cardiac congestion, thereby improving diuretic response. A first-in-man clinical study is currently ongoing.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute heart failure; device therapy; diuretic resistance

Year:  2019        PMID: 31476373     DOI: 10.1016/j.cardfail.2019.08.017

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  3 in total

Review 1.  A Glimpse Into the Future of Transcatheter Interventional Heart Failure Therapies.

Authors:  Roberto C Cerrud-Rodriguez; Daniel Burkhoff; Azeem Latib; Juan F Granada
Journal:  JACC Basic Transl Sci       Date:  2021-11-24

2.  Novel IVC Doraya Catheter Provides Congestion Relief in Patients With Acute Heart Failure.

Authors:  Robert Zymliński; Riet Dierckx; Jan Biegus; Marc Vanderheyden; Jozef Bartunek; Piotr Ponikowski
Journal:  JACC Basic Transl Sci       Date:  2022-04-04

Review 3.  Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification.

Authors:  Cristiano de Oliveira Cardoso; Abdelmotagaly Elgalad; Ke Li; Emerson C Perin
Journal:  Front Cardiovasc Med       Date:  2022-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.